Literature DB >> 20176810

The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif.

Shen-hsi Yang1, Andrew D Sharrocks.   

Abstract

Protein modification by SUMO conjugation has emerged to be an important regulatory event. Recently, the mechanisms through which SUMO elicits its effects on target proteins have been elucidated. One of these is the noncovalent association between SUMO and coregulatory proteins via SUMO interaction motifs (SIMs). We therefore searched for additional binding proteins to elucidate how SUMO acts as a signal to potentiate novel noncovalent interactions with SUMO-binding proteins. We identified an E3 ligase, Pc2, as a SUMO-binding protein with two functionally distinct SIMs. Here, we focus on the role of SIM2 and demonstrate that it is crucial for many of the documented Pc2 functions, which converge on determining its E3 ligase activity. One role of SUMO binding in this context is the subnuclear partitioning of the active form of Ubc9 (SUMO approximately Ubc9) by Pc2. The significance of the SIM2-dependent functions of Pc2 is demonstrated in the control of the precise expression of lineage-specific genes during embryonic stem cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176810      PMCID: PMC2863578          DOI: 10.1128/MCB.01510-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Authors:  M S Rodriguez; C Dargemont; R T Hay
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

Review 2.  SUMO--nonclassical ubiquitin.

Authors:  F Melchior
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.

Authors:  S Sachdev; L Bruhn; H Sieber; A Pichler; F Melchior; R Grosschedl
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

4.  The polycomb protein Pc2 is a SUMO E3.

Authors:  Michael H Kagey; Tiffany A Melhuish; David Wotton
Journal:  Cell       Date:  2003-04-04       Impact factor: 41.582

5.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.

Authors:  Puck Knipscheer; Willem J van Dijk; Jesper V Olsen; Matthias Mann; Titia K Sixma
Journal:  EMBO J       Date:  2007-05-10       Impact factor: 11.598

7.  The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Authors:  Andrea Pichler; Andreas Gast; Jacob S Seeler; Anne Dejean; Frauke Melchior
Journal:  Cell       Date:  2002-01-11       Impact factor: 41.582

8.  Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.

Authors:  Hong-Lin Su; Steven S-L Li
Journal:  Gene       Date:  2002-08-21       Impact factor: 3.688

9.  Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

Authors:  M H Tatham; E Jaffray; O A Vaughan; J M Desterro; C H Botting; J H Naismith; R T Hay
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

10.  A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.

Authors:  Lalitha Subramanian; Mark D Benson; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

View more
  20 in total

Review 1.  SUMO and SUMOylation in plants.

Authors:  Hee Jin Park; Woe-Yeon Kim; Hyeong Cheol Park; Sang Yeol Lee; Hans J Bohnert; Dae-Jin Yun
Journal:  Mol Cells       Date:  2011-09-09       Impact factor: 5.034

2.  Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.

Authors:  Yigit Erker; Helene Neyret-Kahn; Jacob S Seeler; Anne Dejean; Azeddine Atfi; Laurence Levy
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

3.  Entropy-driven mechanism of an E3 ligase.

Authors:  Khue Truong; Yang Su; Jing Song; Yuan Chen
Journal:  Biochemistry       Date:  2011-06-03       Impact factor: 3.162

4.  DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.

Authors:  Federico Pelisch; Berta Pozzi; Guillermo Risso; Manuel Javier Muñoz; Anabella Srebrow
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

5.  Distinctive properties of Arabidopsis SUMO paralogues support the in vivo predominant role of AtSUMO1/2 isoforms.

Authors:  Laura Castaño-Miquel; Josep Seguí; L Maria Lois
Journal:  Biochem J       Date:  2011-06-15       Impact factor: 3.857

Review 6.  E2s: structurally economical and functionally replete.

Authors:  Dawn M Wenzel; Kate E Stoll; Rachel E Klevit
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

Review 7.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

8.  Multiple Arkadia/RNF111 structures coordinate its Polycomb body association and transcriptional control.

Authors:  Huaiyu Sun; Yijing Liu; Tony Hunter
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

9.  Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search.

Authors:  Huaiyu Sun; Tony Hunter
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

10.  The SUMO Conjugation Complex Self-Assembles into Nuclear Bodies Independent of SIZ1 and COP1.

Authors:  Magdalena J Mazur; Mark Kwaaitaal; Manuel Arroyo Mateos; Francesca Maio; Ramachandra K Kini; Marcel Prins; Harrold A van den Burg
Journal:  Plant Physiol       Date:  2018-11-02       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.